These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8691990)

  • 1. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro.
    Cos S; Fernández F; Sánchez-Barceló EJ
    Life Sci; 1996 May; 58(26):2447-53. PubMed ID: 8691990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin.
    Cos S; Recio J; Sánchez-Barceló EJ
    Life Sci; 1996; 58(9):811-6. PubMed ID: 8632728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro.
    Mediavilla MD; Cos S; Sánchez-Barceló EJ
    Life Sci; 1999; 65(4):415-20. PubMed ID: 10421427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wołczyński S; Anchim T; Dziecioł J; Dabrowska M; Pietruczuk M
    Pol J Pathol; 2002; 53(2):59-65. PubMed ID: 12140868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture.
    Cos S; Blask DE; Lemus-Wilson A; Hill AB
    J Pineal Res; 1991 Jan; 10(1):36-42. PubMed ID: 2056430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells.
    Panzer A; Lottering ML; Bianchi P; Glencross DK; Stark JH; Seegers JC
    Cancer Lett; 1998 Jan; 122(1-2):17-23. PubMed ID: 9464486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a "progression factor".
    Dong XF; Berthois Y; Dussert C; Isnardon D; Palmari J; Martin PM
    Anticancer Res; 1992; 12(6B):2085-92. PubMed ID: 1295452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells.
    Maurer M; Komina O; Wesierska-Gadek J
    Ann N Y Acad Sci; 2009 Aug; 1171():250-6. PubMed ID: 19723062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture.
    Hill SM; Blask DE
    Cancer Res; 1988 Nov; 48(21):6121-6. PubMed ID: 3167858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
    Keyomarsi K; Sandoval L; Band V; Pardee AB
    Cancer Res; 1991 Jul; 51(13):3602-9. PubMed ID: 1711413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
    Leung BS; Potter AH
    J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate.
    Cos S; Sánchez-Barceló EJ
    Cancer Lett; 1995 Jul; 93(2):207-12. PubMed ID: 7621430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of melatonin on proliferation of cancer cell lines.
    Papazisis KT; Kouretas D; Geromichalos GD; Sivridis E; Tsekreli OK; Dimitriadis KA; Kortsaris AH
    J Pineal Res; 1998 Dec; 25(4):211-8. PubMed ID: 9885990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells.
    Baldwin WS; Travlos GS; Risinger JI; Barrett JC
    Carcinogenesis; 1998 Nov; 19(11):1895-900. PubMed ID: 9854999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin augments the sensitivity of MCF-7 human breast cancer cells to tamoxifen in vitro.
    Wilson ST; Blask DE; Lemus-Wilson AM
    J Clin Endocrinol Metab; 1992 Aug; 75(2):669-70. PubMed ID: 1639964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gossypol inhibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cells.
    Hu YF; Chang CJ; Brueggemeier RW; Lin YC
    Life Sci; 1993; 53(25):PL433-8. PubMed ID: 8255144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system.
    Cos S; Blask DE
    Cancer Lett; 1990 Apr; 50(2):115-9. PubMed ID: 2328480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation.
    Cos S; Sánchez-Barceló EJ
    Cancer Lett; 1994 Sep; 85(1):105-9. PubMed ID: 7923092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncostatic action of melatonin in an ovarian carcinoma cell line.
    Petranka J; Baldwin W; Biermann J; Jayadev S; Barrett JC; Murphy E
    J Pineal Res; 1999 Apr; 26(3):129-36. PubMed ID: 10231725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.